close
close

The market of peripheral vascular devices is ready for dynamic growth

The market of peripheral vascular devices is ready for dynamic growth

Peripheral Vascular Devices Market Worth $15.86 Billion by 2030 – Exclusive InsightAce Analytic Report

InsightAce Analytics Sp. Ltd. announces the publication of a market assessment report on “Global Peripheral Vascular Devices Market – By Product Type (Aortic Stent Grafts, Arteriotomy Closure Devices, Carotid and Renal Stents, Inferior Vena Caval Filters (IVCF), Peripheral Antiembolic Protection Devices , Peripheral guides, peripheral vascular stents, PTA balloon catheters,

PTA for peripheral drug release, balloon (DEB) catheters, renal denervation catheters, tip localization devices, vascular grafts), end users (hospitals, ambulatory care centers, specialty clinics and others), trends, industry competitive analysis, revenue and forecast for 2030.

Get a free sample copy of the report: https://www.insightaceanalytic.com/request-sample/1054

According to the latest research by InsightAce Analytic, the global peripheral vascular devices market is valued at USD 9.77 billion in 2021 and is expected to reach USD 15.86 billion by 2030, at a CAGR of 5.84% during the forecast period 2024 -2031.

Peripheral vascular devices: a growing market driven by minimally invasive techniques
Peripheral artery disease (PAD), caused by the buildup of atherosclerotic plaque that narrows the arteries in the limbs, can lead to serious health complications. Peripheral vascular devices provide a minimally invasive solution to treating PAD and improving blood flow.

Risk factors and treatment options:
• Smoking, diabetes, obesity and hypertension are the main risk factors for PAD.
• Plaque buildup and arterial blockages are treated with peripheral vascular devices such as aortic stents, peripheral vascular stents, and balloon catheters.

Market growth factors:
• Minimally invasive therapy: Endovascular procedures using these devices provide shorter recovery times and less patient discomfort compared to traditional surgery.

• Aging population: As the population ages, the incidence of PAD is expected to increase, increasing the demand for these devices.

• Increased number of chronic diseases: The increasing incidence of diabetes and obesity contributes to the need for treatment of PAD.

Future perspectives:
• Peripheral catheter research and development is expected to provide significant growth opportunities.

• Rising cases of hypertension and type 2 diabetes are likely to further increase demand for these devices.

• Key players are focusing on product innovation and regulatory approvals to expand their market reach.

Challenges and considerations:
• The risk of infection from peripheral vascular implants requires continued efforts to improve device materials and coatings.

Application:
The peripheral vascular device market is poised for growth due to the rising incidence of PAD, minimally invasive treatment options, and the growing geriatric population. Continued advancements in device technology and a focus on infection prevention will be critical to continued market success.

North America is expected to account for the largest share of the peripheral vascular devices market during the forecast years. The market is expected to grow as more people become aware of the many treatment options available, as technological advances become more widely embraced, and as public and commercial sector investment increases in the peripheral vascular device market.

The regulatory environment for the global North American peripheral vascular device market has also improved due to advances in minimally invasive surgery and increased awareness of peripheral vascular diseases. Moreover, the peripheral vascular devices market in Asia Pacific is expected to grow significantly during the forecast period due to changing dietary trends, aging population,

and increasing knowledge about adapted and modified diets. Due to the huge number of people with unmet medical needs Furthermore, the rapid development of healthcare infrastructure and rising levels of disposable income for patients in emerging economies such as India and China are likely to create future growth opportunities for the global industry.

Major market players operating in the peripheral vascular devices market include:
Abbott Laboratories, Biotronik, Bentley InnoMed GmbH, Boston Scientific Corp, Cardiva Medical Inc., Medtronic plc, WL Gore & Associates Inc, Avascular SLU, B. Braun Melsungen AG, Getinge AB, CR Bard Inc (BD), Cook Medical Inc, Terumo Corp, Cardinal Health Inc., Cordis Corp, Endologix Inc and Terumo Medical Corporation.

Recent collaborations and agreements on the market:
In 2020, Medtronic IN. The PACT AV drug-coated balloon (DCB) is approved by the U.S. Food and Drug Administration for the treatment of arteriovenous fistula lesions.
In 2019, the FDA approved Boston Scientific Corporation’s VICI VENOUS STENT system for the treatment of patients with deep venous blockages.

Are you curious about the latest version of the report? Get report details @ https://www.insightaceanalytic.com/report/global-peripheral-vascular-devices-market/1054

Market segments
Global Vascular Peripheral Devices Market by Product Type, 2022-2030 ($Mn Value)
• Aortic stent grafts
• o Arteriotomy closure devices
• o Carotid and renal artery stents
• o Inferior vena cava filters (IVCF)
• o Peripheral anti-embolism devices
• o Peripheral guides, peripheral vascular stents
• o PTA balloon catheters
• o Peripheral drug secretion PTA
• o Balloon catheters (DEB).
• o Renal denervation catheters
• o Terminal locating devices
• o Vascular grafts

Global Vascular Peripheral Devices Market by End User, 2022-2030 ($Mn Value)
• o Hospitals
• o Ambulatory care centers
• o Specialized clinics
• o Others

Global Peripheral Vascular Devices Market by Region, 2022-2030 ($Mn Value)
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

North America Peripheral Vascular Devices Market, by Country, 2022-2030 (USD Million Value)
• US
• Canada

European Peripheral Vascular Devices Market by Country, 2022-2030 (USD Million Value)
• Germany
• France
• Italy
• Spain
• Russia
• Rest of Europe

Asia Pacific Peripheral Vascular Devices Market, by Country, 2022-2030 (USD Million Value)
• India
• China
• Japan
• South Korea
• Australia and New Zealand

Latin America Peripheral Vascular Devices Market, by Country, 2022-2030 (USD Million Value)
• Brazil
• Mexico
• Rest of Latin America

Middle East and Africa Peripheral Vascular Devices Market, by Country, 2022-2030 (USD Million Value)
• GCC countries
• South Africa
• Rest of the Middle East and Africa

Why you should buy this report:
 To obtain a comprehensive analysis of the prospects of the global Peripheral Vascular Devices market
 To get an overview of the industry and future trends in the Peripheral Vascular Devices market
 To analyze the factors influencing the Peripheral Vascular Devices market and challenges
 To get information on Peripheral Vascular Devices Market Value Forecast (USD Million) by 2030.
 Significant investments, mergers and acquisitions in the peripheral vascular market industry

For more information @ https://www.insightaceanalytic.com/customisation/1054

Contact us:
InsightAce Analytics Sp. Sp. z o. o
Tel.: +1 718 593 4405
E-mail: [email protected]
Site visit: www.insightaceanalytic.com
Follow us on LinkedIn @ bit.ly/2tBXsgS
Follow us on Facebook @ bit.ly/2H9jnDZ

About us:
InsightAce Analytic is a market research and consulting company that empowers clients to make strategic decisions.
Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to grow businesses.
We help clients gain competitive advantage by identifying untapped markets, discovering new and competitive technologies, segmenting potential markets and repositioning products.
Our specialty is delivering syndicated and custom market intelligence reports with in-depth analysis containing key market insights in a timely and cost-effective manner.

This release was published on openPR.